Add to ORKGThe present invention provides a method of improving the efficiency of absorption into the bloodstream of drugs delivered through the pulmonary route. The drug is mixed with surfactant, preferably a surfactant naturally produced by the lung. This method is found to enhance the absorption of pharmaceutical compositions, and in particular those comprising protein, eg insulin, or peptides, eg vasopressin
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a thera...
The large surface area, good vascularization, immense capacity for solute exchange and ultra-thinnes...
Inhalable compositions are described. The inhalable compositions comprise one or more respirable agg...
The present invention relates to formulations for delivery of drugs to the respiratory tract, especi...
Treatment by the pulmonary route can be used for administration of drugs that act locally in the lun...
Abstract: The pulmonary route of administration offers several advantages. First, the lung has a lar...
Pulmonary drugs and genes delivery systems have become an attractive approach in the treatment of lu...
Inhalation of drugs is very efficacious for the treatment of lung diseases and a continuously increa...
Pulmonary surfactant (PS) has been extensively studied because of its primary role in mammalian brea...
Systemic drug delivery using inhalation aerosols presents requirements and challenges. To be well ab...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
The method and system according to preferred embodiments of the present invention allows optimizing ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
To consider the lung as a target for drug delivery and to optimise strategies directed at the pulmon...
Pulmonary surfactant is a complex lipoprotein mixture secreted into the alveo-lar lumen by type 2 pn...
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a thera...
The large surface area, good vascularization, immense capacity for solute exchange and ultra-thinnes...
Inhalable compositions are described. The inhalable compositions comprise one or more respirable agg...
The present invention relates to formulations for delivery of drugs to the respiratory tract, especi...
Treatment by the pulmonary route can be used for administration of drugs that act locally in the lun...
Abstract: The pulmonary route of administration offers several advantages. First, the lung has a lar...
Pulmonary drugs and genes delivery systems have become an attractive approach in the treatment of lu...
Inhalation of drugs is very efficacious for the treatment of lung diseases and a continuously increa...
Pulmonary surfactant (PS) has been extensively studied because of its primary role in mammalian brea...
Systemic drug delivery using inhalation aerosols presents requirements and challenges. To be well ab...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
The method and system according to preferred embodiments of the present invention allows optimizing ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
To consider the lung as a target for drug delivery and to optimise strategies directed at the pulmon...
Pulmonary surfactant is a complex lipoprotein mixture secreted into the alveo-lar lumen by type 2 pn...
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a thera...
The large surface area, good vascularization, immense capacity for solute exchange and ultra-thinnes...
Inhalable compositions are described. The inhalable compositions comprise one or more respirable agg...